• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

DIA Annual Meeting

June 19, 2022
June 23, 2022
CT
McCormick Place, Chicago, IL

For more than 50 years, DIA has been dedicated to providing a neutral and transparent global forum for the exchange of ideas and collaborations to further scientific and medical innovations. The DIA 2022 Global Annual Meeting brings industry, regulators, academics, and patients together to co-create, problem-solve, and discuss global and local challenges facing professionals in the life sciences community. DIA 2022 is the essential meeting for catalyzing knowledge creation and sharing to accelerate healthcare product development. It is an unparalleled experience combining education and networking opportunities that will elevate your skills and knowledge.

How are you improving diversity in your clinical trials? While at DIA, visit our booth #1831 to share your insights in our short survey. For every survey completed, we will make a donation to support CISCRP’s projects that support improving diversity and inclusivity in clinical research. Our experts will also be on hand to discuss how we can partner with you to ensure success for your trials.

Speaking Session Information:

Title: Decentralized Clinical Trials – Real Solutions in Real-Time

Date: Tuesday, June 21st, 2022

Time: 10:20 a.m. – 10:50 a.m. CDT

Location: Exhibit Hall Theater #2

During this Innovation Theater, we’ll poll the audience and explore how you feel about pressing issues and timely DCT topics. Our expert panel includes Jen Horonjeff (Founder/CEO, Savvy Cooperative), Craig Lipset (Co-Chair, DTRA), Bryan McDowell (VP, eCOA Clinical Science, Clario), and moderator Matt McCarty (CMO, Clario). The panel will provide technology, science, and patient perspectives throughout the discussion and offer you real DCT solutions in real-time.

Speakers

Craig Lipset

Advisor and Founder at Clinical Innovation Partners

Craig Lipset is Founder and Managing Partner of Clinical Innovation Partners, a growth advisory practice for clinical trial innovation. He is Co-Chair of the Decentralized Trials & Research Alliance, Assistant Professor of Health Informatics at Rutgers University, and adjunct faculty at the University of Rochester Center for Health and Technology. Craig serves on the Board of Directors for the MedStar Health Research Institute, Foundation for Sarcoidosis Research, and for Circuit Clinical. He is a Venture Partner with Boston Millennia Partners. Craig is a past DIA Annual Meeting Chair, and currently serves on the Regional Advisory Committee for North America.

Jen Horonjeff, PhD

Co-Founder & CEO at Savvy Cooperative

Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy Cooperative, the first and only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better and more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine, alongside the likes of Elon Musk, Chance the Rapper and Reese Witherspoon for her innovative patient engagement model at Savvy. She grew up with multiple autoimmune conditions and survived a brain tumor as an adult, and prior to starting Savvy was a patient-centered outcomes researcher, human factors engineer, human-centered designer, and an FDA advisor. Utilizing her unique perspective, Jen strives to give patients a platform to have their experiences be heard, included, and equitably valued–because the future of healthcare is co-designed with patients.

Matt McCarty headshot

Matt McCarty

Chief Strategy and Marketing Officer at Clario

As Chief Strategy and Marketing Officer at Clario, Matt leads the enterprise’s strategic direction and marketing capabilities. Matt has spent the last 15 years in various executive leadership roles at leading clinical research and commercial healthcare organizations. Most recently, Matt spearheaded the launch of Clario. His work has focused on high-impact product launches (such as Avastin & Herceptin), bringing innovative technology solutions to market, and accelerating the industry-wide adoption of decentralized trials. Matt implemented ICON’s global patient engagement function and served as the first Head of Direct-to-Patient Research (Virtual Trials / DCT) at IQVIA. Prior to that, Matt founded a technology marketing company that was acquired, where he then served as Head of Sales & Marketing.

Bryan McDowell Headshot

Bryan McDowell

VP, eCOA Science & Consulting at Clario

In his role as VP, eCOA Science & Consulting, Bryan brings extensive experience and expertise to achieve smarter drug development, clinical trial design and execution (including decentralized and remote trials) to vastly expand the reach and access of trials to more patients, provide improved patient experience and data quality to deliver accelerated drug & device development programs. Bryan is a thought leader and recognized strategist & visionary and continues to influence, drive and deliver on the pharma wide industry necessity for smarter drug & device development and life cycle management.


Poster Session Information:

Title: BYOD VS. Provisioned Devices: A Cross-Study Exploration of Factors Influencing Patient Compliance

Date: Tuesday, June 21st, 2022

Time: 12:00 p.m. – 1:15 p.m. CDT

Location: Level 3 F2 Entrance

Patients’ ability to submit Patient Reported Outcomes (ePRO) using their own smartphones (BYOD) has the potential to reduce burden and has expanded the reach of hybrid and decentralized trials. Impact on patient compliance is not well understood. The poster presentation discusses the method, results and conclusion of a retrospective analysis of compliance for eCOA on provisioned and BYOD modalities using data collected from 2018-2021.

Presenter

Lindsay Hughes headshot

Lindsay Hughes, PhD

Principal Scientific Advisor at Clario

Dr. Hughes is a scientist with over 15 years of experience in behavioral and life sciences, focusing particularly on the role of human behavior in optimizing health outcomes through prevention, care, and treatment. She is currently a Principal Scientific Advisor at Clario, a global data and technology company that helps to minimize risk in clinical trials. She provides dedicated support to a number of pharmaceutical company sponsors and is the subject matter expert for vaccines and infectious diseases. She has taught courses at the CDC, USAID, and has held international workshops on these issues in more than a dozen countries.